Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

Author： Weizman Abraham   Weizman Ronit  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.1, Iss.3, 2000-08, pp. : 335-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

By Durham L.   Webb Suzin   Milos Patrice   Clary Cathryn   Seymour Albert  

Psychopharmacology, Vol. 174, Iss. 4, 2004-08 ,pp. : 525-529

Springer Publishing Company

Access to resources Recommend Favorite

The role of SSRIs in anxiety disorders

By Nutt D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-261

Elsevier

Access to resources Recommend Favorite

Eating Disorders, Serotonin Transporter Polymorphisms and Potential Treatment Response

By Gorwood P.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite

Inflammation, Serotonin and Major Depression

By  

Current Drug Targets, Vol. 14, Iss. 5, 2013-05 ,pp. : 571-577

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression

By  

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite